Zymeworks Inc.
Pharmaceutical Preparations · 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709
官方登記資料
0位追蹤者
2003成立於
關於 Zymeworks Inc.
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
Source: Wikipedia
產業Pharmaceutical Preparations
總部108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709
成立時間2003
法律形式C Corporation
狀態營運中
專利417 項專利
CYSTEINE ENGINEERED ANTIBODY CONSTRUCTS, CONJUGATES AND METHODS OF USEUS20260042847A1 · 2026
MODIFIED ANTIGEN BINDING POLYPEPTIDE CONSTRUCTS AND USES THEREOFCA3177027C · 2025
關鍵數據
法律資訊
| 法定名稱 | Zymeworks Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1937653在 SEC EDGAR 上查看 ↗ |
| EIN | 88-3099146 |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面